Park Square is pleased to announce the placement of Jerome Riebman, M.D., as Chief Medical Officer at Aziyo Biologics, Inc. Aziyo Biologics, Inc. is a fully integrated regenerative medicine company focused on the development and commercialization of products in orthopedic, cardiovascular, and other medical specialties.

Riebman most recently served in multiple roles at Amgen Pharmaceuticals, including as U.S. Medical Lead, Heart Failure, New Product Development and Director, External Relations and Advocacy, CV, U.S. Medical Organization. Previously, he served as Lead Medical Director, Cardiovascular at Novartis Pharmaceuticals Corporation. 

Riebman received his B.A. and M.A. from Temple University and his M.D. from Temple University School of Medicine. 

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.